US2021230158A1PendingUtilityA1
INHIBITORS OF RORgamma
Est. expiryJul 24, 2037(~11 yrs left)· nominal 20-yr term from priority
C07D 471/04A61P 29/00A61K 31/437C07B 2200/13
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure relates to processes for the production of salts and crystalline forms of a compound having the formula.
Claims
exact text as granted — not AI-modified1 . A method of removing methyl bromide from a composition comprising methyl bromide and crystalline form D bis-hydrogen bromide salt of a compound having the following structural:
comprising:
i) slurrying the composition in a mixture of isopropyl acetate/water or a mixture of heptane/water; and
ii) separating the crystalline form D bis-hydrogen bromide salt from the mixture of isopropyl acetate/water or the mixture of heptane/water.
2 . The method of claim 1 , wherein the composition is slurried in a mixture of isopropyl acetate/water.
3 . The method of claim 1 , wherein the composition is slurried in a mixture of isopropyl acetate comprising 0.25% to 2.5% v/v of water.
4 . The method of claim 1 , wherein the composition is slurried in a mixture of isopropyl acetate comprising 0.5% to 2.0% v/v of water.
5 . The method of claim 1 , wherein the composition is slurried in a mixture of isopropyl acetate comprising 0.9% to 1.1% v/v of water.
6 . The method of claim 1 , wherein the composition comprises greater than 45 ppm of methyl bromide prior to slurrying.
7 . The method of claim 1 , wherein the crystalline form D bis-hydrogen bromide salt after separation comprises less than 40 ppm of methyl bromide.
8 . The method of claim 1 , wherein the crystalline form D bis-hydrogen bromide salt after separation comprises an amount of methyl bromide that is below the level of detection.
9 . The method of claim 1 , wherein the crystalline form D bis-hydrogen bromide salt is separated by filtration.
10 - 14 . (canceled)
15 . A method of forming a compound having the Formula:
comprising the steps of
i) reductively aminating an aldehyde compound represented by the following structural formula:
with an amine compound represented by the following structural formula:
wherein the reductive amination is carried out in the presence of an imine reducing agent;
ii) quenching the reductive amination mixture with acid;
iii) neutralizing the resulting solution with base, thereby precipitating the free base form of the compound; and
iv) isolating the precipitated free-base form of the compound.
16 . The method of claim 15 , further comprising carrying out the reductive amination in ethanol as the solvent.
17 . The method of claim 15 , wherein the acid is hydrochloric acid and the base is sodium hydroxide.
18 . The method of claim 15 , wherein the imine reducing agent is sodium triacetoxyborohydride.
19 . The method of claim 15 , wherein the solution is neutralized in step iii) to pH 5 to 7.
20 . The method of claim 15 , wherein the amine compound is formed in situ from treating an acid salt form of the amine with a tertiary amine base.
21 . The method of claim 15 , wherein the amine is formed in situ from treating a di-hydrochloric acid salt form of the amine with diisopropylethylamine.
22 . The method of claim 15 , further comprising v) adding to the isolated free base, a sufficient amount of hydrobromic acid to form a bis-hydrogen bromide salt having the formula:
23 . The method of claim 22 , further comprising the addition of isopropanol, MTBE, and acetic acid.
24 . The method of claim 22 , wherein said sufficient amount of hydrobromic acid comprises 2 to 3 equivalents of 40% or 48% hydrobromic acid.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.